Get started
Author

Chaiwat Ngampiyaskul

Cognitive Function and Neurodevelopmental Outcomes in HIV-infected Children Older Than 1 Year of Age Randomized to Early Versus Deferred Antiretroviral Therapy
2012 · Thanyawee Puthanakit, Jintanat Ananworanich, et al. · The Pediatric Infectious Disease Journal · 155
Early versus deferred antiretroviral therapy for children older than 1 year infected with HIV (PREDICT): a multicentre, randomised, open-label trial
2012 · Thanyawee Puthanakit, Vonthanak Saphonn, et al. · The Lancet Infectious Diseases · 82
Revisiting the Role of Neutralizing Antibodies in Mother‐to‐Child Transmission of HIV‐1
2006 · Francis Barin, Gonzague Jourdain, et al. · The Journal of Infectious Diseases · 55
Pharmacokinetics and Safety of a New Paediatric Fixed-Dose Combination of Zidovudine/Lamivudine/Nevirapine in HIV-Infected Children
2011 · the IMPAACT P1069 Team, Kulkanya Chokephaibulkit, et al. · Antiviral Therapy · 40
PDF
Once-daily dolutegravir-based antiretroviral therapy in infants and children living with HIV from age 4 weeks: results from the below 14 kg cohort in the randomised ODYSSEY trial
2022 · Pauline Amuge, Abbas Lugemwa, et al. · The Lancet HIV · 36
PDF
Correlation of selenium and zinc levels to antiretroviral treatment outcomes in Thai HIV-infected children without severe HIV symptoms
2012 · T Bunupuradah, S Ubolyam, et al. · European Journal of Clinical Nutrition · 31
Impact of Antiretroviral Therapy on Quality of Life in HIV-Infected Southeast Asian Children in the PREDICT Study
2013 · Torsak Bunupuradah, Pope Kosalaraksa, et al. · AIDS Patient Care and STDs · 29
Increased Risk of Executive Function and Emotional Behavioral Problems Among Virologically Well-Controlled Perinatally HIV-Infected Adolescents in Thailand and Cambodia
2019 · Stephen J. Kerr, Thanyawee Puthanakit, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 25
Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial
2022 · Anna Turkova, Hylke Waalewijn, et al. · The Lancet HIV · 24
PDF
Comparison of Adherence Monitoring Tools and Correlation to Virologic Failure in a Pediatric HIV Clinical Trial
2014 · Jintana Intasan, Torsak Bunupuradah, et al. · AIDS Patient Care and STDs · 23
HIV-related enacted stigma and increase frequency of depressive symptoms among Thai and Cambodian adolescents and young adults with perinatal HIV
2020 · Linda Aurpibul, Jiratchaya Sophonphan, et al. · International Journal of STD & AIDS · 22
PDF
Machine-learning classification of neurocognitive performance in children with perinatal HIV initiating de novo antiretroviral therapy
2019 · Robert H. Paul, Kyu S. Cho, et al. · AIDS · 21
Structural Neuroimaging and Neuropsychologic Signatures in Children With Vertically Acquired HIV
2017 · Robert Paul, Wasana Prasitsuebsai, et al. · The Pediatric Infectious Disease Journal · 20
Soluble CD163 and monocyte populations in response to antiretroviral therapy and in relationship with neuropsychological testing among HIV-infected children
2015 · Jintanat Ananworanich, Stephen J. Kerr, et al. · Journal of Virus Eradication · 19
PDF
Emotional and behavioral resilience among children with perinatally acquired HIV in Thailand and Cambodia
2019 · Kathleen M. Malee, Stephen Kerr, et al. · AIDS · 18
Prevalence and Clinical Outcomes of Poor Immune Response Despite Virologically Suppressive Antiretroviral Therapy Among Children and Adolescents With Human Immunodeficiency Virus in Europe and Thailand: Cohort Study
2019 · Elizabeth Chappell, Andrew Riordan, et al. · Clinical Infectious Diseases · 18
PDF
Virological outcomes and genotypic resistance on dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: a secondary analysis of the ODYSSEY trial
2025 · Ellen White, Cissy Kityo, et al. · The Lancet HIV · 17
Nucleoside/nucleotide reverse transcriptase inhibitor sparing regimen with once daily integrase inhibitor plus boosted darunavir is non-inferior to standard of care in virologically-suppressed children and adolescents living with HIV – Week 48 results of the randomised SMILE Penta-17-ANRS 152 clinical trial
2023 · Alexandra Compagnucci, Man K. Chan, et al. · EClinicalMedicine · 17
PDF
Prevalence of Human Leukocyte Antigen-B*5701 Among HIV-infected Children in Thailand and Cambodia
2012 · Thanyawee Puthanakit, Torsak Bunupuradah, et al. · The Pediatric Infectious Disease Journal · 17
Neuropsychiatric manifestations and sleep disturbances with dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: a secondary analysis of the ODYSSEY trial
2023 · Anna Turkova, Ellen White, et al. · The Lancet Child & Adolescent Health · 14
PDF
Prevalence of Anemia and Underlying Iron Status in Naive Antiretroviral Therapy HIV-Infected Children with Moderate Immune Suppression
2012 · Pope Kosalaraksa, Torsak Bunupuradah, et al. · AIDS Research and Human Retroviruses · 14
Brief Report: AIDS-Defining Events and Deaths in HIV-Infected Children and Adolescents on Antiretrovirals: A 14-Year Study in Thailand
2017 · Patrinee Traisathit, Tristan Delory, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 12
Incidence of Tuberculosis and Associated Mortality in a Cohort of Human Immunodeficiency Virus-Infected Children Initiating Antiretroviral Therapy
2017 · Nicolas Salvadori, Nicole Ngo-Giang-Huong, et al. · Journal of the Pediatric Infectious Diseases Society · 12
PDF
Cognition, Emotional Health, and Immunological Markers in Children With Long-Term Nonprogressive HIV
2018 · Robert Paul, Tanakorn Apornpong, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 11
Poor quality of life among untreated Thai and Cambodian children without severe HIV symptoms
2011 · Torsak Bunupuradah, Thanyawee Puthanakit, et al. · AIDS Care · 11
Works count: 50
Citation count: 809
H-index: 17
I10-index: 26
Year
Topic
Type